TiGenix
Trending Articles
Related Content
Regulatory
Takeda announces its intention to acquire TiGenix
Takeda Pharmaceutical has announced its intention to launch a voluntary conditional takeover bid on TiGenix, an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for serious medical conditions
Manufacturing
TiGenix expands manufacturing facility
TiGenix obtains commercial production licence for expanded manufacturing facility, to provide the capacity for potential European commercial roll out of investigational stem cell therapy, Cx601; the expansion also secures manufacturing for other pipeline products